Skip to main content

Technology

By HIMSS TV | 07:00 am | December 30, 2022
The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.
By Jessica Hagen | 12:27 pm | December 29, 2022
Ian Shakil, founder, director and chief strategy officer at Augmedix, discusses the company's role in the evolution of medical documentation.
By Emily Olsen | 11:50 am | December 29, 2022
Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.
By HIMSS TV | 07:00 am | December 29, 2022
James Hury, the Translational Research Institute for Space Health's deputy director and chief innovation officer explains the ways space exploration companies work with healthcare innovators to examine astronaut health and advance healthcare on the ground.
By Jessica Hagen and Emily Olsen | 01:15 pm | December 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
By Jessica Hagen | 12:17 pm | December 28, 2022
Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   
By Jessica Hagen | 11:25 am | December 27, 2022
The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.
By HIMSS TV | 07:00 am | December 27, 2022
Grace Chang, cofounder and CEO of Kintsugi, says that the use of machine learning voice and biomarker technology can help spot clinical depression and anxiety in regular health discussions.
By Adam Ang | 01:56 am | December 23, 2022
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
By Emily Olsen | 07:20 pm | December 22, 2022
The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.